Literature DB >> 3134492

Monoclonal antibodies to the rough lipopolysaccharide of Neisseria meningitidis protect infant rats from meningococcal infection.

K Saukkonen1, M Leinonen, H Käyhty, H Abdillahi, J T Poolman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3134492     DOI： 10.1093/infdis/158.1.209

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

Review 1.  Animal models for pathogenic Neisseria species.

Authors:  R J Arko
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

2.  Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.

Authors:  Lisa A Lewis; David M Vu; Dan M Granoff; Sanjay Ram
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Purification, cyanogen bromide cleavage, and amino terminus sequencing of class 1 and class 3 outer membrane proteins of meningococci.

Authors:  J T Poolman; H A Timmermans; T Teerlink; R C Seid
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Differences in surface expression of NspA among Neisseria meningitidis group B strains.

Authors:  G R Moe; S Tan; D M Granoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.

Authors:  Kenneth T Mountzouros; Kelly A Belanger; Alan P Howell; Garvin S Bixler; Dace V Madore
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.

Authors:  Svein Rune Andersen; Terry Guthrie; Geoffrey R Guile; Jan Kolberg; Sam Hou; Lisa Hyland; Simon Y C Wong
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes.

Authors:  J J Kim; N J Phillips; B W Gibson; J M Griffiss; R Yamasaki
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes.

Authors:  A B Petrov; B F Semenov; Y P Vartanyan; M M Zakirov; V P Torchilin; V S Trubetskoy; N V Koshkina; V L L'Vov; I K Verner; I V Lopyrev
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.